Core Laboratories (NYSE:CLB – Get Free Report) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 0.120-0.160 for the period, compared to the consensus EPS estimate of 0.210. The company issued revenue guidance of $121.0 million-$127.0 million, compared to the consensus revenue estimate of $131.7 million.
Wall Street Analyst Weigh In
Several brokerages have recently commented on CLB. Citigroup lowered their target price on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating for the company in a report on Thursday, October 31st. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Two investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to MarketBeat.com, Core Laboratories has a consensus rating of “Hold” and a consensus target price of $17.00.
Check Out Our Latest Research Report on CLB
Core Laboratories Price Performance
Core Laboratories (NYSE:CLB – Get Free Report) last released its earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.43%. On average, equities research analysts forecast that Core Laboratories will post 0.96 earnings per share for the current year.
Core Laboratories Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Monday, February 10th will be paid a $0.01 dividend. The ex-dividend date is Monday, February 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.23%. Core Laboratories’s payout ratio is presently 6.06%.
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
See Also
- Five stocks we like better than Core Laboratories
- The Significance of Brokerage Rankings in Stock Selection
- 3 Turnaround Stocks in the Early Innings With More Upside to Come
- How to Evaluate a Stock Before Buying
- Whirlpool: Buy This High-Yielding Value Before It Spins Higher
- How to invest in marijuana stocks in 7 steps
- Commvault Systems: Share Price Primed to Vault Higher in 2025
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.